Ben Davidson

29PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Liquid biopsiesCancer diagnosisMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Feb 08, 2026
The specificity of HEG1 as mesothelioma marker depends on the differential diagnosis.

Ben Davidson, Lara Maria Stričak, Arild Holth

|Apr 02, 2025
The Diagnostic Role of TFF1, TFF3, FOXA1, CA XII and TRPS1 in Serous Effusions.

Ben Davidson, Arild Holth, Jeremias Wohlschlaeger

|Sep 05, 2024
Endometrial carcinomas with ambiguous histology often harbor TP53 mutations.

Ben Davidson, Karin Teien Lande, Daniel Nebdal

|May 11, 2024
Molecular characteristics of tubo-ovarian carcinosarcoma at different anatomic locations.

Ben Davidson, Arild Holth, Kristina Lindemann

|Dec 23, 2023
Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance.

Margarida Varela Dos Santos, Arild Holth, Katharina Bischof

|Dec 15, 2023
Molecular features for timely cancer diagnosis and treatment - tumors of the ovary, fallopian tube and endometrium.

Sonia Gatius, Xavier Matias Guiu, Ben Davidson

Pageof 5

Frequent Collaborators

2 joint publications

Karianne G Fleten

2 joint publications

Kjersti Flatmark

1 joint publications

Yvonne Andersson

1 joint publications

Annette Torgunrud